Indraprastha Medical Corporation Limited
has reported a total income of Rs198.7cr during the fourth quarter ended March 31, 2021, as compared to Rs200.5cr during the same quarter last year, a drop of 1.2% yoy. The total income in Q3FY21 was Rs180cr. During FY21, total income declined to Rs613.38cr compared to Rs830.76cr in FY20.
The company has posted a net profit of Rs15.10cr for the period ended March 31, 2021 as against net profit of Rs6.5cr for the period ended March 31, 2020, an increase of 132.5%. Net profit during FY21 was Rs2.32cr as against net profit of Rs43.62cr in FY20.
The company has reported EPS of Rs1.65 for the period ended March 31, 2021 as compared to Rs0.71 for the period ended March 31, 2020. For FY21, EPS was Rs0.23 as compared to Rs4.76 in FY20.
At around 10.47 AM, Indraprastha Medical Corporation Ltd. was trading at Rs95.50 per piece down Rs3.20 or 3.24% on the BSE.